EU side-effects database expanded
To cover nationally-approved medicines
Suspected side-effects of medicines that have been authorised by national regulators within the European Union (EU) can now be reported to a web-accessed database that has thus far focused on drugs with central EU market approvals.
EU patients and healthcare professionals are now being encouraged to make such reports on the 1,700 active substances in nationally-approved pharmaceuticals.